Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Kaitlyn M Maddra, Rui Li, Anna S Nagle, Adam P Klausner & John E Speich. (2022) Repeatability of Ultrasound-Defined Bladder Shape Metrics in Healthy Volunteers. Research and Reports in Urology 14, pages 185-192.
Read now
Read now
Alice Wang, Elizabeth Rourke, Elisabeth Sebesta & Roger Dmochowski. (2021) Axonics® system for treatment of overactive bladder syndrome and urinary urgency incontinence. Expert Review of Medical Devices 18:8, pages 727-732.
Read now
Read now
Sara Kjaer Bastholm, Lena Aadal & Camilla Biering Lundquist. (2019) Electrical stimulation on urinary symptoms following stroke: a systematic review. European Journal of Physiotherapy 21:2, pages 73-82.
Read now
Read now
Cristina Palmer, Bilal Farhan, Nobel Nguyen & Gamal Ghoniem. (2019) Clinical outcomes of percutaneous tibial nerve stimulation in elderly patients with overactive bladder. Arab Journal of Urology 17:1, pages 10-13.
Read now
Read now
Zalmai Hakimi, Jameel Nazir, Charles McCrea, Malin Berling, Francis Fatoye, Barbara Ramos & Adrian Wagg. (2017) Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada. Journal of Medical Economics 20:6, pages 614-622.
Read now
Read now
Howard B. Goldman, Jean-Jacques Wyndaele, Steven A. Kaplan, Joseph T. Wang & Fady Ntanios. (2014) Defining response and non-response to treatment in patients with overactive bladder: a systematic review. Current Medical Research and Opinion 30:3, pages 509-526.
Read now
Read now
Alex Gomelsky & Roger R Dmochowski. (2012) Oxybutynin gel for the treatment of overactive bladder. Expert Opinion on Pharmacotherapy 13:9, pages 1337-1343.
Read now
Read now
Pamela Ellsworth. (2012) Treatment of Overactive Bladder Symptoms beyond Antimuscarinics: Current and Future Therapies. Postgraduate Medicine 124:3, pages 16-27.
Read now
Read now
Alex Gomelsky & Roger R Dmochowski. (2011) Update on the management of overactive bladder: patient considerations and adherence. Open Access Journal of Urology 3, pages 7-17.
Read now
Read now
Jerilyn M Latini & Antonella Giannantoni. (2011) Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder. Expert Opinion on Pharmacotherapy 12:7, pages 1017-1027.
Read now
Read now
Lonny Green & Donna Kerney. (2011) Patient experience with darifenacin – results of a short-term community-based survey in managing overactive bladder. Current Medical Research and Opinion 27:2, pages 431-437.
Read now
Read now
Articles from other publishers (80)
David Sheyn, Natalie Chakraborty, Yufan Brandon Chen, Sangeeta T. MahajanAdonis Hijaz. (2023) Use of a Digital Conversational Agent for the Management of Overactive Bladder. Urogynecology.
Crossref
Crossref
Zhaofeng Jin, Qiumin Zhang, Yanlan Yu, Ruilin Zhang, Guoqing Ding, Tian Li & Yuping Song. (2023) Progress in overactive bladder: novel avenues from psychology to clinical opinions. PeerJ 11, pages e16112.
Crossref
Crossref
Tsung Mou, Oluwateniola Brown, Siyuan Dong, Shameem Abbasy, Vania Leung & Melissa Simon. (2023) Exploratory mixed methods study on care-seeking behaviors of Asian Americans with pelvic floor symptoms. International Urogynecology Journal 34:10, pages 2557-2564.
Crossref
Crossref
Cindy Tay & Luke Grundy. (2023) Animal models of interstitial cystitis/bladder pain syndrome. Frontiers in Physiology 14.
Crossref
Crossref
Stephanie Gleicher, W. Stuart Reynolds, Roger R. Dmochowski & Elisabeth M. Sebesta. (2023) Assessment of OAB Education for Urologic Trainees. Current Bladder Dysfunction Reports.
Crossref
Crossref
Keerati Chiengthong & Suvit Bunyavejchevin. (2023) Efficacy of Erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial. Menopause 30:4, pages 414-420.
Crossref
Crossref
Hoan M. VuVan T. H. TranHuy Q. HoangBo HanBa X. Hoang. (2023) Efficacy and Tolerability of Ich Nieu Khang Dietary Supplement for Overactive Bladder. Journal of Medicinal Food 26:4, pages 262-269.
Crossref
Crossref
Anirban Ganguly, Shachi Tyagi, Christopher Chermansky, Anthony Kanai, Jonathan Beckel, Mamoru Hashimoto, Kang Jun Cho, Michael Chancellor, Jonathan Kaufman, Naoki Yoshimura & Pradeep Tyagi. (2023) Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options. Drugs & Aging 40:3, pages 241-261.
Crossref
Crossref
Yoav Baruch, Marco Torella, Sarah De Bastiani, Michele Meschia, Massimo Candiani, Nicola Colacurci & Stefano Salvatore. (2023) Pre- versus Post-Menopausal Onset of Overactive Bladder and the Response to Vaginal Estrogen Therapy: A Prospective Study. Medicina 59:2, pages 245.
Crossref
Crossref
Alain P. Bourcier & Jean A. Juras. 2023. Female Genitourinary and Pelvic Floor Reconstruction. Female Genitourinary and Pelvic Floor Reconstruction
221
253
.
Beverly Rosa Williams, Kathryn L. Burgio, Jeni Hebert‐Beirne, Aimee James, Kimberly Kenton, Daphne Yvette LaCoursiere, Leslie Rickey, Sonya S. Brady, Lisa Kane Low & Diane K. Newman. (2022) A multisite focus group study of US adult women's beliefs and assumptions about bladder health and function. Neurourology and Urodynamics 41:7, pages 1590-1600.
Crossref
Crossref
Sonya S. Brady, Tamara G. Bavendam, Christine K. Bradway, Britt Conroy, Annemarie Dowling-Castronovo, Cynthia Neill Epperson, Adonis K. Hijaz, Ryan S. Hsi, Karen Huss, Michelle Kim, Jason Lazar, Richard K. Lee, Christine K. Liu, Christine N. Loizou, Saadia Miran, Lona Mody, Jenna M. Norton, William Stuart Reynolds, Siobhan Sutcliffe, Nicole Zhang & James A. Hokanson. (2022) Noncancerous Genitourinary Conditions as a Public Health Priority: Conceptualizing the Hidden Burden. Urology 166, pages 39-49.
Crossref
Crossref
Naoko Izumi, Tomohiro Matsuo & Yoshihisa Matsukawa. (2022) Associations among Physician–Patient Communication, Patient Satisfaction, and Clinical Effectiveness of Overactive Bladder Medication: A Survey of Patients with Overactive Bladder. Journal of Clinical Medicine 11:14, pages 4087.
Crossref
Crossref
O. I. Ivakhnenko, E. V. Derkach, V. S. Krysanova, A. D. Ermolaeva & K. A. Kokushkin. (2022) Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice:1, pages 30-40.
Crossref
Crossref
Susana Martinez Díaz, Hudson Pierce, John Richard Lee, Tirsit Asfaw, Andrew Abram, Naeem Bhojani, Dean Elterman, Kevin Zorn & Bilal Chughtai. (2022) A Community-Based Education Program for Overactive Bladder in a Predominantly Minority Older Female Population: A Pilot Study. Urologia Internationalis 106:7, pages 664-671.
Crossref
Crossref
Alain P. Bourcier & Jean A. Juras. 2022. Female Genitourinary and Pelvic Floor Reconstruction. Female Genitourinary and Pelvic Floor Reconstruction
1
33
.
Chuying Qin, Yinhuai Wang & Yunliang Gao. (2021) Overactive Bladder Symptoms Within Nervous System: A Focus on Etiology. Frontiers in Physiology 12.
Crossref
Crossref
Su-Jin Yang, Jung Ha Park, Yunhwan Oh, Hyeonju Kim, Mihee Kong & Jihyun Moon. (2021) Association of decreased grip strength with lower urinary tract symptoms in women: a cross‐sectional study from Korea. BMC Women's Health 21:1.
Crossref
Crossref
Soyeon Kim, Jung Ha Park, Yun Hwan Oh, Hyeon Ju Kim, Mi Hee Kong & Jihyun Moon. (2021) Correlation between neutrophil to lymphocyte ratio and overactive bladder in South Korean women: a community-based, cross-sectional study. BMJ Open 11:10, pages e048309.
Crossref
Crossref
Kurt McCammon, Angelo Gousse, Alfred Kohan, David Glazier, Jennifer Gruenenfelder, Zhanying Bai, Anand Patel & Douglass Hale. (2021) Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial. Female Pelvic Medicine & Reconstructive Surgery 27:7, pages 450-456.
Crossref
Crossref
Victor W. Nitti, Anand Patel & Mickey Karram. (2021) Diagnosis and management of overactive bladder: A review. Journal of Obstetrics and Gynaecology Research 47:5, pages 1654-1665.
Crossref
Crossref
Jiho Lee, Eunkyoung Park, Wonok Kang, Yuri Kim, Kyu-Sung Lee & Sung-Min Park. (2021) An Efficient Noninvasive Neuromodulation Modality for Overactive Bladder Using Time Interfering Current Method. IEEE Transactions on Biomedical Engineering 68:1, pages 214-224.
Crossref
Crossref
Liping Xia, Huilei Yan, Yalei Sun, Yan Zhu, Yudong Wu, Zhipeng Chen & Shunye Su. (2021) Pooled analysis of the efficacy and safety of tibial nerve stimulation versus antimuscarinic agents in the management of overactive bladder syndrome. Medicine 100:45, pages e27745.
Crossref
Crossref
Maxime T. M. Kummeling, Joost Egberts, Henk W. Elzevier, Gommert A. van Koeveringe, Hein Putter & Pieter M. Groenendijk. (2020) Exploratory analysis of the effect of mirabegron on urodynamic sensation parameters and urethral pressure variations. International Urogynecology Journal 32:1, pages 87-93.
Crossref
Crossref
Jeffrey A. Linder, Joel S. Weissman, Harry Reyes Nieva, Stuart Lipsitz, R. Sterling Haring, Julie DeAngelis, Rita M. Kristy & Kevin R. Loughlin. (2020) Overactive bladder in an integrated delivery system: a longitudinal cohort study. BMC Health Services Research 20:1.
Crossref
Crossref
Cora Fogaing, Abubakr H. Mossa & Lysanne Campeau. (2020) Are Beta 3 Adrenergic Agonists Now the Preferred Pharmacologic Management of Overactive Bladder?. Current Urology Reports 21:12.
Crossref
Crossref
Eunkyoung Park, Jae-Woong Lee, Taekyung Kim, Minhee Kang, Baek Hwan Cho, Jiho Lee, Sung-Min Park & Kyu-Sung Lee. (2020) The long-lasting post-stimulation inhibitory effects of bladder activity induced by posterior tibial nerve stimulation in unanesthetized rats. Scientific Reports 10:1.
Crossref
Crossref
Lunan Ji, Elisabeth M. Sebesta, Sarah E. Stumbar, Matthew P. Rutman & Doreen E. Chung. (2020) Evaluating the Quality of Overactive Bladder Patient Education Material on YouTube: A Pilot Study Using the Patient Education Materials Assessment Tool. Urology 145, pages 90-93.
Crossref
Crossref
Benjamin M. Brucker, Richard K. Lee & Diane K. Newman. (2020) Optimizing Nonsurgical Treatments of Overactive Bladder in the United States. Urology 145, pages 52-59.
Crossref
Crossref
Anna C. Kirby, Sungchul Park, Sara B. Cook, Katherine Odem-Davis, John L. GoreErika M. Wolff. (2020) Practice Patterns for Women With Overactive Bladder Syndrome: Time Between Medications and Third-Line Treatments. Female Pelvic Medicine & Reconstructive Surgery 26:7, pages 431-436.
Crossref
Crossref
Omar Al Hussein Alawamlh, Bashir Al Hussein Al Awamlh, Una Lee & Richard K. Lee. (2020) Overactive Bladder in Women: an Update for Primary Care Physicians. Current Bladder Dysfunction Reports 15:1, pages 44-52.
Crossref
Crossref
Justina Tam, Wai Lee & Jason Kim. 2020. Female Pelvic Surgery. Female Pelvic Surgery
49
64
.
Sophia Delpe Goodridge & Roger R. Dmochowski. 2019. Contemporary Pharmacotherapy of Overactive Bladder. Contemporary Pharmacotherapy of Overactive Bladder
115
131
.
Jameel Nazir, Zalmai Hakimi, Florent Guelfucci, Amine Khemiri, Francis Fatoye, Ana María Mora Blázquez & Marta Hernández González. (2018) A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain. BMC Urology 18:1.
Crossref
Crossref
David A. Ginsberg, Marcus J. Drake, Albert Kaufmann, Sidney Radomski, Angelo E. Gousse, Christopher J. Chermansky, Andrew Magyar, Jean Paul Nicandro & Victor W. Nitti. (2017) Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder. The Journal of Urology 198:4, pages 897-904.
Crossref
Crossref
So Young Kim, Woojin Bang & Hyo Geun Choi. (2017) Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women. PLOS ONE 12:9, pages e0185592.
Crossref
Crossref
Christopher R. Chapple, Jameel Nazir, Zalmai Hakimi, Sally Bowditch, Francis Fatoye, Florent Guelfucci, Amine Khemiri, Emad Siddiqui & Adrian Wagg. (2017) Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice. European Urology 72:3, pages 389-399.
Crossref
Crossref
Jenna M. Norton, Jennifer L. Dodson, Diane K. Newman, Rebecca G. Rogers, Andrea D. Fairman, Helen L. Coons, Robert A. Star & Tamara G. Bavendam. (2017) Nonbiologic factors that impact management in women with urinary incontinence: review of the literature and findings from a National Institute of Diabetes and Digestive and Kidney Diseases workshop. International Urogynecology Journal 28:9, pages 1295-1307.
Crossref
Crossref
Alexandra Fortin, Valérie Morin, Sophie Ramsay, Pascale Gervais & Stéphane Bolduc. (2017) Adherence to antimuscarinics in children with overactive bladder. Paediatrics & Child Health 22:5, pages 255-258.
Crossref
Crossref
Hendrikje M.K. van Breda, Frank M.J. Martens, Johnny Tromp & John P.F.A. Heesakkers. (2017) A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. The Journal of Urology 198:1, pages 205-210.
Crossref
Crossref
Cristina J. Palmer & Judy M. Choi. (2017) Pathophysiology of Overactive Bladder: Current Understanding. Current Bladder Dysfunction Reports 12:1, pages 74-79.
Crossref
Crossref
Satoko TAKAOKA, Yoshie KONDO, Yasue KOBAYASHI & Tamami TANIGUCHI. (2017) Evaluation of the relationship between postpartum lower urinary tract symptoms and QOL: Examination using the comprehensive questionnaire, SF-12ver.2. Journal of Japan Academy of Midwifery 31:1, pages 78-87.
Crossref
Crossref
Maxime T.M. Kummeling, Peter F.W.M. Rosier, Henk W. Elzevier & Pieter M. Groenendijk. (2017) Continuous urethral pressure measurements; measurement techniques; pressure variations; clinical interpretations; and clinical relevance. A Systematic Literature Analysis. Neurourology and Urodynamics 36:1, pages 51-56.
Crossref
Crossref
Tamara G. Bavendam, Jenna M. Norton, Ziya Kirkali, Chris Mullins, John W. Kusek, Robert A. Star & Griffin P. Rodgers. (2016) Advancing a Comprehensive Approach to the Study of Lower Urinary Tract Symptoms. Journal of Urology 196:5, pages 1342-1349.
Crossref
Crossref
Vik Khullar, Gerard Amarenco, Javier C. Angulo, Mary Beth Blauwet, Jameel Nazir, Isaac A. Odeyemi & Zalmai Hakimi. (2015)
Patient‐reported outcomes with the β
3
‐adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder
. Neurourology and Urodynamics 35:8, pages 987-994.
Crossref
Crossref
Ariana L. Smith, Liisa Hantsoo, Anna P. Malykhina, Daniel W. File, Rita Valentino, Alan J. Wein, Mary D. Sammel & C. Neill Epperson. (2016) Basal and stress-activated hypothalamic pituitary adrenal axis function in postmenopausal women with overactive bladder. International Urogynecology Journal 27:9, pages 1383-1391.
Crossref
Crossref
W. Stuart Reynolds, Jay Fowke & Roger Dmochowski. (2016) The Burden of Overactive Bladder on US Public Health. Current Bladder Dysfunction Reports 11:1, pages 8-13.
Crossref
Crossref
Tae Heon KimKyu-Sung Lee. (2016) Persistence and compliance with medication management in the treatment of overactive bladder. Investigative and Clinical Urology 57:2, pages 84.
Crossref
Crossref
Debbie Kinsey, Sara Pretorius, Lesley Glover & Tim Alexander. (2014) The psychological impact of overactive bladder: A systematic review. Journal of Health Psychology 21:1, pages 69-81.
Crossref
Crossref
Nitesh Patidar, Varun Mittal, Manoj Kumar, Sanjoy Kumar Sureka, Sohrab Arora & Mohd. Sualeh Ansari. (2015) Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report. Journal of Pediatric Urology 11:6, pages 351.e1-351.e6.
Crossref
Crossref
Frank A Filipetto, Kimberly G Fulda, Amy E Holthusen, Thomas M McKeithen & Pam McFadden. (2014) The patient perspective on overactive bladder: a mixed-methods needs assessment. BMC Family Practice 15:1.
Crossref
Crossref
Niels V. Johnsen, David J. Osborn & Roger R. Dmochowski. (2014) The role of electrical stimulation techniques in the management of the male patient with urgency incontinence. Current Opinion in Urology 24:6, pages 560-565.
Crossref
Crossref
Judy Yuen-man Siu. (2014) The Illness Experiences of Women with Overactive Bladder in Hong Kong. Qualitative Health Research 24:6, pages 801-810.
Crossref
Crossref
Hendrikje M. K. van Breda & John P. F. A. Heesakkers. (2013) Neuromodulation for Voiding Dysfunction: When and How Best to Use. Current Bladder Dysfunction Reports 9:1, pages 41-47.
Crossref
Crossref
Vik Khullar, Monserrat Espuna-Pons, Daniela Marschall-Kehrel, Aino Fianu-Jonasson, Con J. Kelleher, Linda Brubaker, James Beach, Elisabeth Piault & Jeffrey Trocio. (2014) Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms. Neurourology and Urodynamics 33:1, pages 90-94.
Crossref
Crossref
Jamie Bartley, Jason Gilleran & Kenneth Peters. (2013) Neuromodulation for overactive bladder. Nature Reviews Urology 10:9, pages 513-521.
Crossref
Crossref
Vik Khullar, Daniela Marschall-Kehrel, Montserrat Espuna-Pons, Con J. Kelleher, Shannon E. Tully, Elisabeth C. Piault, Linda Brubaker, Aino Fianu-Jonasson, David Weinstein, Agneta Bergqvist & Marion Kvasz. (2013) European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder. International Urogynecology Journal 24:9, pages 1529-1536.
Crossref
Crossref
Kenneth M. Peters, Donna J. Carrico, Leslie S. Wooldridge, Christopher J. Miller & Scott A. MacDiarmid. (2013) Percutaneous Tibial Nerve Stimulation for the Long-Term Treatment of Overactive Bladder: 3-Year Results of the STEP Study. The Journal of Urology 189:6, pages 2194-2201.
Crossref
Crossref
Christopher R ChappleAlex GomelskyRoger R Dmochowski. 2013. Contemporary Management of Overactive Bladder. Contemporary Management of Overactive Bladder
24
37
.
Lisa M Schafer, Clarissa Hsu, Emery Rose Eaves, Cheryl Ritenbaugh, Judith Turner, Daniel C Cherkin, Colette Sims & Karen J Sherman. (2012) Complementary and alternative medicine (CAM) providers’ views of chronic low back pain patients’ expectations of CAM therapies: a qualitative study. BMC Complementary and Alternative Medicine 12:1.
Crossref
Crossref
Sherilyn M Notte, Thomas S Marshall, Misun Lee, Zalmai Hakimi, Isaac Odeyemi, Wen-Hung Chen & Dennis A Revicki. (2012) Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder. BMC Urology 12:1.
Crossref
Crossref
Murat Onal, Funda Gungor Ugurlucan & Onay Yalcin. (2012) The effects of posterior tibial nerve stimulation on refractory overactive bladder syndrome and bladder circulation. Archives of Gynecology and Obstetrics 286:6, pages 1453-1457.
Crossref
Crossref
Ian Milsom, Steven A. Kaplan, Karin S. Coyne, Chris C. Sexton & Zoe S. Kopp. (2012) Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS. Urology 80:1, pages 90-96.
Crossref
Crossref
Y.C. Chen, S.C. Ng, S.L. Chen, Y.H. Huang, S.W. Hu & G.D. Chen. (2011) Overactive bladder in Taiwanese women: Re‐analysis of epidemiological database of community from 1999 to 2001. Neurourology and Urodynamics 31:1, pages 56-59.
Crossref
Crossref
C. C. Sexton, S. M. Notte, C. Maroulis, R. R. Dmochowski, L. Cardozo, D. Subramanian & K. S. Coyne. (2011) Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. International Journal of Clinical Practice 65:5, pages 567-585.
Crossref
Crossref
Fah Che Leong, Mary T. McLennan, Susan A. Barr & Andrew C. Steele. (2011) Posterior Tibial Nerve Stimulation in Patients Who Have Failed Anticholinergic Therapy. Female Pelvic Medicine & Reconstructive Surgery 17:2, pages 74-75.
Crossref
Crossref
Ragi Doggweiler. (2010) Will Posterior Tibial Nerve Stimulation Replace Sacral Nerve Root Stimulation as the Salvage Management of Drug Resistant Urinary Urge Incontinence?. The Journal of Urology 184:5, pages 1835-1836.
Crossref
Crossref
Amitabha Majumdar, Ismail Hassan, Sepeedeh Saleh & Philip Toozs-Hobson. (2010) Inpatient bladder retraining: is it beneficial on its own?. International Urogynecology Journal 21:6, pages 657-663.
Crossref
Crossref
Kenneth M. Peters, Donna J. Carrico, Ramon A. Perez-Marrero, Ansar U. Khan, Leslie S. Wooldridge, Gregory L. Davis & Scott A. MacDiarmid. (2010) Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial. The Journal of Urology 183:4, pages 1438-1443.
Crossref
Crossref
Roger R. Dmochowski, Matt T. Rosenberg, Norm R. Zinner, David R. Staskin & Peter K. Sand. (2010) Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder. Value in Health 13:2, pages 251-257.
Crossref
Crossref
E. Martínez Agulló, J.L. Ruíz Cerdá, L. Gómez Pérez, P. Rebollo, M. Pérez & J. Chaves. (2010) Impacto de la incontinencia urinaria y del síndrome de vejiga hiperactiva en la calidad de vida relacionada con la salud de pacientes de mediana edad laboralmente activos y mayores de 65 años institucionalizados. Actas Urológicas Españolas 34:3, pages 242-250.
Crossref
Crossref
Scott A. MacDiarmid, Kenneth M. Peters, S. Abbas Shobeiri, Leslie S. Wooldridge, Eric S. Rovner, Fah Che Leong, Steven W. Siegel, Susan B. Tate & Brian A. Feagins. (2010) Long-Term Durability of Percutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder. The Journal of Urology 183:1, pages 234-240.
Crossref
Crossref
E. Martínez Agulló, J.L. Ruíz Cerdá, L. Gómez Pérez, P. Rebollo, M. Pérez & J. Chaves. (2010) Impact of urinary incontinence and overactive bladder syndrome on health-related quality of life of working middle-aged patients and institutionalized elderly patients. Actas Urológicas Españolas (English Edition) 34:3, pages 242-250.
Crossref
Crossref
Peter K. Sand, Roger R. Dmochowski, Norman R. Zinner, David R. Staskin & Rodney A. Appell. (2009) Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome. International Urogynecology Journal 20:12, pages 1431-1438.
Crossref
Crossref
Alex Gomelsky & Roger R. Dmochowski. (2009) Overactive bladder in males. Therapeutic Advances in Urology 1:4, pages 209-221.
Crossref
Crossref
Kenneth M. Peters, Scott A. MacDiarmid, Leslie S. Wooldridge, Fah Che Leong, S. Abbas Shobeiri, Eric S. Rovner, Steven W. Siegel, Susan B. Tate, Barry K. Jarnagin, Peter L. Rosenblatt & Brian A. Feagins. (2009) Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial. The Journal of Urology 182:3, pages 1055-1061.
Crossref
Crossref
J. F. Wyman, K. L. Burgio & D. K. Newman. (2009) Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. International Journal of Clinical Practice 63:8, pages 1177-1191.
Crossref
Crossref
Diane K. Newman. 2009. Continence. Continence
521
531
.
Mel Lauti, Peter Herbison, Jean Hay-Smith, Gaye Ellis & Don Wilson. (2008) Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial. International Urogynecology Journal 19:11, pages 1533-1543.
Crossref
Crossref
. (2007) Current World Literature. Current Opinion in Obstetrics & Gynecology 19:6, pages 596-605.
Crossref
Crossref